Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02409043 · ClinicalTrials.gov registry record
Neuronal and Glial Biomarkers in Stroke
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 99
- Enrollment target
NCT02409043: Completed study, sponsored by University of Florida.
NCT02409043 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02409043 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if there are molecules in the blood that indicate when a person has had a stroke, and what type of stroke they have had, so that appropriate treatment may be begun as soon as possible. This study is also being conducted to determine whether these molecules can help to predict long-term health following stroke. Some of these potential molecules, also called biomarkers, include Neuronal biomarker ubiquitin C-terminal hydrolase-L1 (UCH-L1), Glial markers such as glial fibrillary acidic protein (GFAP), and a neuroprotective enzyme called angiotensin converting enzyme 2 (ACE2), which has activity that has been shown to be helpful cardiovascular disease and shown to be altered in animal models of acute stroke, where it is also shown to provide neuronal protection.
Primary Outcome
Serum and whole blood will be analyzed for levels of ACE2 activity. These markers will be assessed for their value as biomarkers of stroke subtype and long-term outcome.
Interventions
- OTHER Blood draw
- OTHER Stroke blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-12 |
What the finished NCT02409043 record still lists
NCT02409043 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT02409043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02409043 about?
NCT02409043 is a clinical study titled "Neuronal and Glial Biomarkers in Stroke". The purpose of this research study is to determine if there are molecules in the blood that indicate when a person has had a stroke, and what type of stroke they have had, so that appropriate treatment may be begun as soon as possible. This study is also being conducted to determine whether these mo...
What is the current status of trial NCT02409043?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2014-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02409043?
The interventions under investigation include: Blood draw (OTHER), Stroke blood draw (OTHER).
Who is sponsoring clinical trial NCT02409043?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia